Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests

Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests

Homozygous or double heterozygous factor XIII (FXIII) deficiency is characterized by soft tissue hematomas, intracranial and delayed spontaneous bleeding. Alterations of thromboelastography (TEG) parameters in these patients have been reported. The aim of the study was to show results of TEG, TEG Ly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mediterranean journal of hematology and infectious diseases 2016-08, Vol.8 (1), p.e2016037-e2016037
Hauptverfasser: Martinuzzo, M, Barrera, L, Altuna, D, Baña, F Tisi, Bieti, J, Amigo, Q, D'Adamo, M, López, M S, Oyhamburu, J, Otaso, J C
Format: Artikel
Sprache:eng
Schlagworte:
Original
Thrombolytic drugs
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e2016037
container_issue 1
container_start_page e2016037
container_title Mediterranean journal of hematology and infectious diseases
container_volume 8
creator Martinuzzo, M
Barrera, L
Altuna, D
Baña, F Tisi
Bieti, J
Amigo, Q
D'Adamo, M
López, M S
Oyhamburu, J
Otaso, J C
description Homozygous or double heterozygous factor XIII (FXIII) deficiency is characterized by soft tissue hematomas, intracranial and delayed spontaneous bleeding. Alterations of thromboelastography (TEG) parameters in these patients have been reported. The aim of the study was to show results of TEG, TEG Lysis (Lys 60) induced by subthreshold concentrations of streptokinase (SK), and to compare them to the clot solubility studies results in samples of a 1-year-old girl with homozygous or double heterozygous FXIII deficiency. A year one girl with a history of bleeding from the umbilical cord. During her first year of life, several hematomas appeared in soft upper limb tissue after punctures for vaccination and a gluteal hematoma. One additional sample of a heterozygous patient and three samples of acquired FXIII deficiency were also evaluated. Clotting tests, von Willebrand factor (vWF) antigen and activity, plasma FXIII-A subunit (pFXIII-A) were measured by an immunoturbidimetric assay in a photo-optical coagulometer. Solubility tests were performed with Ca(2+)-5 M urea and thrombin-2% acetic acid. Basal and post-FXIII concentrate infusion samples were studied. TEG was performed with CaCl2 or CaCl2 + SK (3.2 U/mL) in a Thromboelastograph. Prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time, fibrinogen, factor VIIIc, vWF, and platelet aggregation were normal. Antigenic pFXIII-A subunit was < 2%. TEG, evaluated at diagnosis and post FXIII concentrate infusion (pFXIII-A= 37%), presented a normal reaction time (R), 8 min, prolonged k (14 and 11min respectively), a low Maximum-Amplitude (MA) ( 39 and 52 mm respectively), and Clot Lysis (Lys60) slightly increased (23 and 30% respectively). In the sample at diagnosis, clot solubility was abnormal, 50 and 45 min with Ca-Urea and thrombin-acetic acid, respectively, but normal (>16 hours) 1-day post-FXIII infusion. Analysis of FXIII deficient and normal plasma mixtures (< 2-102% of pFXIII-A), showed that Ca-urea solubility was abnormal at pFXIII-A < 9%, thrombin-acetic acid at pFXIII-A
doi_str_mv 10.4084/MJHID.2016.037
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5016016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1822118571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-e95ff053781c803229ad55ce6d0b5b173a8792ab9b539fcc02e5c5b2ceeefd703</originalsourceid><addsrcrecordid>eNptUU1LJDEQDYvLKq5Xj0tgL15mzMdkOn1ZkFF3WkY8zAjemnS6YsftTsYk7TI_Zv_rBnQXFYuCKl49Hq-qEDqmZDojcnZ6fbWszqeM0PmU8OITOmCEiwknZL73qt9HRzE-kBycU8nZF7TPivlMMkIO0J8LY0CniL3Bl0onH_BdVVX4HIzVFpzeYe_wpgt-aDz0KiZ_H9S2200_AvFvmzq8UL2244CVa_E6Bdgm_8s6FQGfta1NNgvaiAcfAK_BxYw8AU6dcnjt-7GxvU07vIGY4lf02ag-wtFLPUS3lxebxXKyuvlZLc5WE815mSZQCmOI4IWkWhLOWKlaITTMW9KIhhZcyaJkqikbwUujNWEgtGiYBgDTFoQfoh_PutuxGaDV4FJQfb0NdlBhV3tl67cTZ7v63j_VIt8-ZxY4eREI_nHM1uvBRg19rxz4MdZUMkapFAXN1O_vqA9-DC6vV9NSUCokmZWZ9e21o_9W_n2O_wXwyZ-R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1951158049</pqid></control><display><type>article</type><title>Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Martinuzzo, M ; Barrera, L ; Altuna, D ; Baña, F Tisi ; Bieti, J ; Amigo, Q ; D'Adamo, M ; López, M S ; Oyhamburu, J ; Otaso, J C</creator><creatorcontrib>Martinuzzo, M ; Barrera, L ; Altuna, D ; Baña, F Tisi ; Bieti, J ; Amigo, Q ; D'Adamo, M ; López, M S ; Oyhamburu, J ; Otaso, J C</creatorcontrib><description>Homozygous or double heterozygous factor XIII (FXIII) deficiency is characterized by soft tissue hematomas, intracranial and delayed spontaneous bleeding. Alterations of thromboelastography (TEG) parameters in these patients have been reported. The aim of the study was to show results of TEG, TEG Lysis (Lys 60) induced by subthreshold concentrations of streptokinase (SK), and to compare them to the clot solubility studies results in samples of a 1-year-old girl with homozygous or double heterozygous FXIII deficiency. A year one girl with a history of bleeding from the umbilical cord. During her first year of life, several hematomas appeared in soft upper limb tissue after punctures for vaccination and a gluteal hematoma. One additional sample of a heterozygous patient and three samples of acquired FXIII deficiency were also evaluated. Clotting tests, von Willebrand factor (vWF) antigen and activity, plasma FXIII-A subunit (pFXIII-A) were measured by an immunoturbidimetric assay in a photo-optical coagulometer. Solubility tests were performed with Ca(2+)-5 M urea and thrombin-2% acetic acid. Basal and post-FXIII concentrate infusion samples were studied. TEG was performed with CaCl2 or CaCl2 + SK (3.2 U/mL) in a Thromboelastograph. Prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time, fibrinogen, factor VIIIc, vWF, and platelet aggregation were normal. Antigenic pFXIII-A subunit was &lt; 2%. TEG, evaluated at diagnosis and post FXIII concentrate infusion (pFXIII-A= 37%), presented a normal reaction time (R), 8 min, prolonged k (14 and 11min respectively), a low Maximum-Amplitude (MA) ( 39 and 52 mm respectively), and Clot Lysis (Lys60) slightly increased (23 and 30% respectively). In the sample at diagnosis, clot solubility was abnormal, 50 and 45 min with Ca-Urea and thrombin-acetic acid, respectively, but normal (&gt;16 hours) 1-day post-FXIII infusion. Analysis of FXIII deficient and normal plasma mixtures (&lt; 2-102% of pFXIII-A), showed that Ca-urea solubility was abnormal at pFXIII-A &lt; 9%, thrombin-acetic acid at pFXIII-A&lt;18%, but TEG MA and elasticity at 23% and Lys60 with SK at pFXIII-A&lt; 40%. TEG parameters MA and elasticity, and Lys 60 in TEG either with Ca(2+) or Ca(2+) and SK are more sensitive to low levels of pFXIII than solubility tests. The increased Lys60 induced by a subthreshold concentration of SK could probably reflect the clot characteristics "in vivo" in many patients with pFXIII levels between 5-40% and could be potentially considered as screening test.</description><identifier>ISSN: 2035-3006</identifier><identifier>EISSN: 2035-3006</identifier><identifier>DOI: 10.4084/MJHID.2016.037</identifier><identifier>PMID: 27648200</identifier><language>eng</language><publisher>Italy: Mattioli 1885 SpA</publisher><subject>Original ; Thrombolytic drugs</subject><ispartof>Mediterranean journal of hematology and infectious diseases, 2016-08, Vol.8 (1), p.e2016037-e2016037</ispartof><rights>2016. This work is licensed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-e95ff053781c803229ad55ce6d0b5b173a8792ab9b539fcc02e5c5b2ceeefd703</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016016/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016016/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27648200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martinuzzo, M</creatorcontrib><creatorcontrib>Barrera, L</creatorcontrib><creatorcontrib>Altuna, D</creatorcontrib><creatorcontrib>Baña, F Tisi</creatorcontrib><creatorcontrib>Bieti, J</creatorcontrib><creatorcontrib>Amigo, Q</creatorcontrib><creatorcontrib>D'Adamo, M</creatorcontrib><creatorcontrib>López, M S</creatorcontrib><creatorcontrib>Oyhamburu, J</creatorcontrib><creatorcontrib>Otaso, J C</creatorcontrib><title>Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests</title><title>Mediterranean journal of hematology and infectious diseases</title><addtitle>Mediterr J Hematol Infect Dis</addtitle><description>Homozygous or double heterozygous factor XIII (FXIII) deficiency is characterized by soft tissue hematomas, intracranial and delayed spontaneous bleeding. Alterations of thromboelastography (TEG) parameters in these patients have been reported. The aim of the study was to show results of TEG, TEG Lysis (Lys 60) induced by subthreshold concentrations of streptokinase (SK), and to compare them to the clot solubility studies results in samples of a 1-year-old girl with homozygous or double heterozygous FXIII deficiency. A year one girl with a history of bleeding from the umbilical cord. During her first year of life, several hematomas appeared in soft upper limb tissue after punctures for vaccination and a gluteal hematoma. One additional sample of a heterozygous patient and three samples of acquired FXIII deficiency were also evaluated. Clotting tests, von Willebrand factor (vWF) antigen and activity, plasma FXIII-A subunit (pFXIII-A) were measured by an immunoturbidimetric assay in a photo-optical coagulometer. Solubility tests were performed with Ca(2+)-5 M urea and thrombin-2% acetic acid. Basal and post-FXIII concentrate infusion samples were studied. TEG was performed with CaCl2 or CaCl2 + SK (3.2 U/mL) in a Thromboelastograph. Prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time, fibrinogen, factor VIIIc, vWF, and platelet aggregation were normal. Antigenic pFXIII-A subunit was &lt; 2%. TEG, evaluated at diagnosis and post FXIII concentrate infusion (pFXIII-A= 37%), presented a normal reaction time (R), 8 min, prolonged k (14 and 11min respectively), a low Maximum-Amplitude (MA) ( 39 and 52 mm respectively), and Clot Lysis (Lys60) slightly increased (23 and 30% respectively). In the sample at diagnosis, clot solubility was abnormal, 50 and 45 min with Ca-Urea and thrombin-acetic acid, respectively, but normal (&gt;16 hours) 1-day post-FXIII infusion. Analysis of FXIII deficient and normal plasma mixtures (&lt; 2-102% of pFXIII-A), showed that Ca-urea solubility was abnormal at pFXIII-A &lt; 9%, thrombin-acetic acid at pFXIII-A&lt;18%, but TEG MA and elasticity at 23% and Lys60 with SK at pFXIII-A&lt; 40%. TEG parameters MA and elasticity, and Lys 60 in TEG either with Ca(2+) or Ca(2+) and SK are more sensitive to low levels of pFXIII than solubility tests. The increased Lys60 induced by a subthreshold concentration of SK could probably reflect the clot characteristics "in vivo" in many patients with pFXIII levels between 5-40% and could be potentially considered as screening test.</description><subject>Original</subject><subject>Thrombolytic drugs</subject><issn>2035-3006</issn><issn>2035-3006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNptUU1LJDEQDYvLKq5Xj0tgL15mzMdkOn1ZkFF3WkY8zAjemnS6YsftTsYk7TI_Zv_rBnQXFYuCKl49Hq-qEDqmZDojcnZ6fbWszqeM0PmU8OITOmCEiwknZL73qt9HRzE-kBycU8nZF7TPivlMMkIO0J8LY0CniL3Bl0onH_BdVVX4HIzVFpzeYe_wpgt-aDz0KiZ_H9S2200_AvFvmzq8UL2244CVa_E6Bdgm_8s6FQGfta1NNgvaiAcfAK_BxYw8AU6dcnjt-7GxvU07vIGY4lf02ag-wtFLPUS3lxebxXKyuvlZLc5WE815mSZQCmOI4IWkWhLOWKlaITTMW9KIhhZcyaJkqikbwUujNWEgtGiYBgDTFoQfoh_PutuxGaDV4FJQfb0NdlBhV3tl67cTZ7v63j_VIt8-ZxY4eREI_nHM1uvBRg19rxz4MdZUMkapFAXN1O_vqA9-DC6vV9NSUCokmZWZ9e21o_9W_n2O_wXwyZ-R</recordid><startdate>20160816</startdate><enddate>20160816</enddate><creator>Martinuzzo, M</creator><creator>Barrera, L</creator><creator>Altuna, D</creator><creator>Baña, F Tisi</creator><creator>Bieti, J</creator><creator>Amigo, Q</creator><creator>D'Adamo, M</creator><creator>López, M S</creator><creator>Oyhamburu, J</creator><creator>Otaso, J C</creator><general>Mattioli 1885 SpA</general><general>Università Cattolica del Sacro Cuore</general><scope>NPM</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160816</creationdate><title>Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests</title><author>Martinuzzo, M ; Barrera, L ; Altuna, D ; Baña, F Tisi ; Bieti, J ; Amigo, Q ; D'Adamo, M ; López, M S ; Oyhamburu, J ; Otaso, J C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-e95ff053781c803229ad55ce6d0b5b173a8792ab9b539fcc02e5c5b2ceeefd703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Original</topic><topic>Thrombolytic drugs</topic><toplevel>online_resources</toplevel><creatorcontrib>Martinuzzo, M</creatorcontrib><creatorcontrib>Barrera, L</creatorcontrib><creatorcontrib>Altuna, D</creatorcontrib><creatorcontrib>Baña, F Tisi</creatorcontrib><creatorcontrib>Bieti, J</creatorcontrib><creatorcontrib>Amigo, Q</creatorcontrib><creatorcontrib>D'Adamo, M</creatorcontrib><creatorcontrib>López, M S</creatorcontrib><creatorcontrib>Oyhamburu, J</creatorcontrib><creatorcontrib>Otaso, J C</creatorcontrib><collection>PubMed</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Mediterranean journal of hematology and infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martinuzzo, M</au><au>Barrera, L</au><au>Altuna, D</au><au>Baña, F Tisi</au><au>Bieti, J</au><au>Amigo, Q</au><au>D'Adamo, M</au><au>López, M S</au><au>Oyhamburu, J</au><au>Otaso, J C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests</atitle><jtitle>Mediterranean journal of hematology and infectious diseases</jtitle><addtitle>Mediterr J Hematol Infect Dis</addtitle><date>2016-08-16</date><risdate>2016</risdate><volume>8</volume><issue>1</issue><spage>e2016037</spage><epage>e2016037</epage><pages>e2016037-e2016037</pages><issn>2035-3006</issn><eissn>2035-3006</eissn><abstract>Homozygous or double heterozygous factor XIII (FXIII) deficiency is characterized by soft tissue hematomas, intracranial and delayed spontaneous bleeding. Alterations of thromboelastography (TEG) parameters in these patients have been reported. The aim of the study was to show results of TEG, TEG Lysis (Lys 60) induced by subthreshold concentrations of streptokinase (SK), and to compare them to the clot solubility studies results in samples of a 1-year-old girl with homozygous or double heterozygous FXIII deficiency. A year one girl with a history of bleeding from the umbilical cord. During her first year of life, several hematomas appeared in soft upper limb tissue after punctures for vaccination and a gluteal hematoma. One additional sample of a heterozygous patient and three samples of acquired FXIII deficiency were also evaluated. Clotting tests, von Willebrand factor (vWF) antigen and activity, plasma FXIII-A subunit (pFXIII-A) were measured by an immunoturbidimetric assay in a photo-optical coagulometer. Solubility tests were performed with Ca(2+)-5 M urea and thrombin-2% acetic acid. Basal and post-FXIII concentrate infusion samples were studied. TEG was performed with CaCl2 or CaCl2 + SK (3.2 U/mL) in a Thromboelastograph. Prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time, fibrinogen, factor VIIIc, vWF, and platelet aggregation were normal. Antigenic pFXIII-A subunit was &lt; 2%. TEG, evaluated at diagnosis and post FXIII concentrate infusion (pFXIII-A= 37%), presented a normal reaction time (R), 8 min, prolonged k (14 and 11min respectively), a low Maximum-Amplitude (MA) ( 39 and 52 mm respectively), and Clot Lysis (Lys60) slightly increased (23 and 30% respectively). In the sample at diagnosis, clot solubility was abnormal, 50 and 45 min with Ca-Urea and thrombin-acetic acid, respectively, but normal (&gt;16 hours) 1-day post-FXIII infusion. Analysis of FXIII deficient and normal plasma mixtures (&lt; 2-102% of pFXIII-A), showed that Ca-urea solubility was abnormal at pFXIII-A &lt; 9%, thrombin-acetic acid at pFXIII-A&lt;18%, but TEG MA and elasticity at 23% and Lys60 with SK at pFXIII-A&lt; 40%. TEG parameters MA and elasticity, and Lys 60 in TEG either with Ca(2+) or Ca(2+) and SK are more sensitive to low levels of pFXIII than solubility tests. The increased Lys60 induced by a subthreshold concentration of SK could probably reflect the clot characteristics "in vivo" in many patients with pFXIII levels between 5-40% and could be potentially considered as screening test.</abstract><cop>Italy</cop><pub>Mattioli 1885 SpA</pub><pmid>27648200</pmid><doi>10.4084/MJHID.2016.037</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2035-3006
ispartof Mediterranean journal of hematology and infectious diseases, 2016-08, Vol.8 (1), p.e2016037-e2016037
issn 2035-3006
2035-3006
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5016016
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Original
Thrombolytic drugs
title Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T18%3A54%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Factor%20XIII%20Deficiency%20on%20Thromboelastography.%20Thromboelastography%20with%20Calcium%20and%20Streptokinase%20Addition%20is%20more%20Sensitive%20than%20Solubility%20Tests&rft.jtitle=Mediterranean%20journal%20of%20hematology%20and%20infectious%20diseases&rft.au=Martinuzzo,%20M&rft.date=2016-08-16&rft.volume=8&rft.issue=1&rft.spage=e2016037&rft.epage=e2016037&rft.pages=e2016037-e2016037&rft.issn=2035-3006&rft.eissn=2035-3006&rft_id=info:doi/10.4084/MJHID.2016.037&rft_dat=%3Cproquest_pubme%3E1822118571%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1951158049&rft_id=info:pmid/27648200&rfr_iscdi=true